CD8A and familial pancreatic carcinoma: Vanhersecke et al, found that the presence of mature TLS improved the objective response rate, prolonged progression-free survival, and TLS was independent of PD-L1 expression level and the amount of infiltrating CD8+ T cells in primary pancreatic cancer patients who received anti-PD-1/PD-L1 antibody therapy (24).